E. coli Infections
Learn about E. coli infections, including Escherichia coli infections, E. coli UTI, and E. coli sepsis. This resource provides information on diagnosis, clinical documentation, and medical coding for healthcare professionals. Find details on E. coli infection symptoms, treatment, and prevention. Understand relevant medical terminology and coding guidelines for accurate documentation and billing related to E. coli infections.
Infection caused by the bacteria Escherichia coli, commonly found in the intestines.
Symptoms vary depending on the infection site but may include diarrhea, abdominal pain, fever, and urinary urgency.
Community-acquired, healthcare-associated, foodborne, and waterborne.
ICD-10 Code Families
Complete code families applicable to A04.4
When to use each related code
| Description | When to use |
|---|---|
| Infection caused by E. coli bacteria. | Use for infections confirmed as E. coli, including UTI, sepsis, or other manifestations. |
| Urinary tract infection (UTI). | Use for UTIs when the causative organism is unknown or unspecified. Consider E. coli Infections if confirmed. |
| Sepsis, a life-threatening organ dysfunction caused by infection. | Use for sepsis from any infectious agent. Code E. coli Infections separately if E. coli is identified as the cause. |
Best-practice checklist
- ✓Document E. coli infection site (e.g., UTI, bloodstream)
- ✓Specify E. coli strain if known (e.g., O157:H7)
- ✓Document signs/symptoms (e.g., fever, diarrhea, dysuria)
- ✓Record lab results confirming E. coli (e.g., culture, PCR)
- ✓Note patient's medical history relevant to infection
Common pitfalls to avoid
Coding E. coli sepsis requires clear documentation of organ dysfunction due to infection, not just positive culture.
E. coli UTI coding needs documentation specifying upper (pyelonephritis) or lower UTI (cystitis, urethritis).
Coding unspecified E. coli infection lacks clinical detail. Document specific manifestations and location.
Best-practice tips
- 01Proper hand hygiene prevents E. coli transmission (ICD-10 A04.0-A04.7).
- 02Accurate urine cultures key for E. coli UTI diagnosis (N00-N99).
- 03Timely antibiotic stewardship combats E. coli resistance (J01).
- 04Thorough stool cultures crucial for E. coli infection identification (A04.7).
- 05Meat thermometer use prevents E. coli from food (A05.4).
Step-by-step checklist
- 1
Verify urine culture for E. coli (ICD-10: N39.0, B96.2)
- 2
Check patient history for UTI symptoms (frequency, urgency, dysuria)
- 3
Assess for sepsis indicators (fever, hypotension, tachycardia, elevated WBC)
- 4
Review antibiotic sensitivities and local resistance patterns (E. coli resistance)
- 5
Consider risk factors: age, comorbidities, recent antibiotic use
Ready-to-paste narrative
Patient presents with symptoms suggestive of an E. coli infection. Differential diagnosis includes Escherichia coli urinary tract infection (UTI), E. coli sepsis, bacteremia, gastroenteritis, and other infectious processes. Presenting complaints may include urinary frequency, urgency, dysuria, fever, chills, flank pain, abdominal pain, nausea, vomiting, or diarrhea depending on the site of infection. In cases of suspected urosepsis or E. coli bloodstream infection, the patient may exhibit signs of systemic inflammatory response syndrome (SIRS) such as tachycardia, tachypnea, and altered mental status. Physical examination findings may reveal costovertebral angle tenderness, suprapubic tenderness, or abdominal guarding. Preliminary diagnostic workup includes urinalysis with microscopy, urine culture and sensitivity, complete blood count (CBC) with differential, blood cultures if sepsis is suspected, and potentially stool cultures if gastroenteritis is considered. Treatment for E. coli infections typically involves antibiotic therapy, with specific antibiotic selection guided by culture and sensitivity results. Commonly prescribed antibiotics include trimethoprim-sulfamethoxazole, nitrofurantoin, fluoroquinolones, or cephalosporins. Patient education regarding proper hydration, hygiene, and medication adherence is crucial. Further investigations such as imaging studies (e.g., CT scan of the abdomen and pelvis) may be warranted depending on the clinical picture and severity of the infection. Monitoring for treatment response and potential complications, including renal failure in severe cases, is essential. ICD-10 codes for E. coli infections may include B96.20 (E. coli as the cause of diseases classified elsewhere), N39.0 (Urinary tract infection, site not specified), A49.9 (Bacterial infection, unspecified), or A04.71 (Enterocolitis due to E. coli). Appropriate CPT codes for evaluation and management, laboratory tests, and procedures will be documented based on services rendered.
Common questions and answers
What are the most effective empiric antibiotic treatment options for complicated E. coli urinary tract infections (UTIs) in adult patients with suspected extended-spectrum beta-lactamase (ESBL) production?+
Empiric treatment for complicated E. coli UTIs with suspected ESBL production requires careful consideration of local resistance patterns and patient-specific factors. Carbapenems, such as ertapenem or meropenem, are often the preferred initial choice due to their broad-spectrum activity against ESBL-producing organisms. However, increasing carbapenem resistance necessitates antibiotic stewardship. Other options with activity against ESBL-producing E. coli include newer beta-lactam/beta-lactamase inhibitor combinations like ceftolozane/tazobactam or ceftazidime/avibactam. Urine culture and sensitivity testing should be performed to guide definitive therapy, allowing de-escalation to a narrower-spectrum agent whenever possible. Explore how local antibiograms can inform your empiric antibiotic choices for complicated UTIs. Consider implementing rapid diagnostic testing to facilitate prompt and appropriate treatment decisions. Learn more about the latest guidelines for the management of resistant gram-negative infections.
How can clinicians differentiate between uncomplicated and complicated E. coli infections to ensure accurate diagnosis and targeted treatment strategies?+
Distinguishing between uncomplicated and complicated E. coli infections is crucial for effective management. Uncomplicated infections typically involve healthy, non-pregnant individuals with infections limited to the lower urinary tract (cystitis). Complicated infections, on the other hand, affect patients with structural or functional abnormalities of the urinary tract, comorbidities like diabetes or immunosuppression, or infections extending beyond the bladder (e.g., pyelonephritis, urosepsis). Pregnancy also categorizes a UTI as complicated. Accurate diagnosis involves a thorough patient history, physical examination, and urinalysis. Imaging studies, such as ultrasound or CT scan, may be indicated for complicated infections to evaluate for anatomical abnormalities or abscess formation. Consider implementing standardized diagnostic criteria to improve the accuracy and consistency of differentiating between uncomplicated and complicated E. coli infections. Explore how risk stratification can help personalize treatment strategies. Learn more about the role of biomarkers in identifying complicated UTIs.
Beyond antibiotics, what non-pharmacological interventions can clinicians implement to improve patient outcomes in recurrent E. coli UTI cases, particularly in women?+
Non-pharmacological interventions play a significant role in managing recurrent E. coli UTIs, especially in women. Patient education on hygiene practices, including proper perineal care and voiding habits, is essential. Increasing fluid intake can help flush bacteria from the urinary tract. Cranberry products, though their efficacy remains debated, may offer some benefit in preventing recurrence in certain patients. Topical estrogen therapy can be considered for postmenopausal women experiencing recurrent UTIs related to vaginal atrophy. For patients with recurrent UTIs associated with sexual activity, prophylactic antibiotics may be discussed. Explore the potential benefits of probiotics in preventing recurrent UTIs. Consider implementing a shared decision-making approach to personalize non-pharmacological interventions for each patient. Learn more about the latest research on behavioral modifications for UTI prevention.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.